← All stocks

BIODESIX INC

BDSX No buying or selling
CIK 0001439725 #3725 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

12 insiders · 0 transactions
1.8×

Scott Hutton holds only 1.8 times base salary in stock. $1.19M of shares against $643.40K in salary for 2025.

Salary from the company's own proxy. The shares are what Scott Hutton last reported holding, valued at $24.47, the price Common Stock was last bought or sold at on the open market here, on 12 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Kennedy Lawrence T. Jr
Director
10,411,024
$254.72M
+1.0%
Strobeck Matthew
Director
2,606,879
$63.78M
+1.6%
PATIENCE JOHN
Director
2,178,681
$53.30M
+7.4%
SCHULER JACK W
10% owner
555,810
$13.60M
Watts Charles M
Director
421,705
$10.32M
+12.4%
MASSARANY HANY
Director
363,499
$8.89M
+15.5%
Franchi Jean M.
Director
108,140
$2.65M
+32.2%
Hutton Scott
President & CEO
48,767
$1.19M
Cowie Robin Harper
CFO, Sec'y & Treasurer
16,231
$397.11K
Pestano Gary Anthony
Chief Development Officer
10,359
$253.44K
O'Kane Kieran
Chief Commercial Officer
9,819
$240.23K
Vazquez Chris
Chief Accounting Officer
1,586
$38.80K

No percentages here. This company's share count has moved by a factor of 18.4 over the window, from 7,955,685 to 146,633,352 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 3 Nov 2020